Immune Checkpoint Inhibitor-induced Dermatitis
📧 Sign up to get email alerts when something new happens for Immune Checkpoint Inhibitor-induced Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis [Phase 2]
Phase 2 clinical trial evaluating JAK inhibitors for solid tumor patients with dermatitis refractory to immune checkpoint inhibitor therapy.